Literature DB >> 26928222

Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes.

Aidar R Gosmanov1, Jun L Lu, Keiichi Sumida, Praveen K Potukuchi, Connie M Rhee, Kamyar Kalantar-Zadeh, Miklos Z Molnar, Csaba P Kovesdy.   

Abstract

OBJECTIVES: Hemoglobin A1c levels less than 7.0% and systolic blood pressure (SBP) less than 140 mmHg are each associated with lower risk of vascular complications in patients with diabetes mellitus. Associations between combined A1c level and SBP categories and risk of mortality and morbidity in diabetic patients are not well characterized.
METHODS: We examined 891 670 US diabetic veterans with baseline estimated glomerular filtration rates more than 60 ml/min per 1.73 m (mean age 67 ± 11 years, 97% men, 17% African-Americans). The associations of mutually exclusive combined categories of A1c (<6.5, 6.5-6.9, 7.0-7.9, 8.0-8.9, 9.0-9.9, and ≥10%) and SBP (<100, 100-119, 120-139, 140-159, 160-179, and ≥180 mmHg) with the risk of all-cause mortality and incident chronic kidney disease (CKD), coronary heart disease, and stroke were examined in Cox models adjusted for baseline characteristics using patients with concomitant A1c 6.5-6.9% and SBP of 120-139 mmHg as the referent group.
RESULTS: A total of 221 529 (25%) patients died, and 178 588 (20%), 43 373 (5%) and 36 935 (4%) developed CKD, coronary heart disease and stroke, respectively, during a median follow-up of 7.4 years. SBP displayed a J-shaped association with each outcome except CKD risk that was linearly associated with SBP across all A1c categories. A1c above 7.0% was associated with monotonically worse outcomes for all end points in all SBP categories. Patients with the combined highest A1c and SBP levels experienced the worst outcomes.
CONCLUSION: SBP greater than 120-139 mmHg and A1c greater than 7.0% are associated with higher mortality and vascular complications in diabetic patients, independent of each other. Combined efforts to improve both glycemic and blood pressure control may synergistically improve outcomes in patients with normal kidney function.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26928222      PMCID: PMC5705006          DOI: 10.1097/HJH.0000000000000864

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  36 in total

1.  Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.

Authors:  Faramarz Ismail-Beigi; Timothy E Craven; Patrick J O'Connor; Diane Karl; Jorge Calles-Escandon; Irene Hramiak; Saul Genuth; William C Cushman; Hertzel C Gerstein; Jeffrey L Probstfield; Lois Katz; Ulrich Schubart
Journal:  Kidney Int       Date:  2011-12-14       Impact factor: 10.612

2.  Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.

Authors:  Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

3.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

4.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

5.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.

Authors:  P Reichard; B Y Nilsson; U Rosenqvist
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

6.  Effect of a multifactorial intervention on mortality in type 2 diabetes.

Authors:  Peter Gaede; Henrik Lund-Andersen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

7.  Prevalence of and Racial Disparities in Risk Factor Control in Older Adults With Diabetes: The Atherosclerosis Risk in Communities Study.

Authors:  Christina M Parrinello; Ina Rastegar; Job G Godino; Michael D Miedema; Kunihiro Matsushita; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2015-04-07       Impact factor: 19.112

8.  The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.

Authors:  Sarah Stark Casagrande; Judith E Fradkin; Sharon H Saydah; Keith F Rust; Catherine C Cowie
Journal:  Diabetes Care       Date:  2013-02-15       Impact factor: 19.112

Review 9.  Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review.

Authors:  Ann D Colosia; Roberto Palencia; Shahnaz Khan
Journal:  Diabetes Metab Syndr Obes       Date:  2013-09-17       Impact factor: 3.168

10.  Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.

Authors:  Karen L Margolis; Patrick J O'Connor; Timothy M Morgan; John B Buse; Robert M Cohen; William C Cushman; Jeffrey A Cutler; Gregory W Evans; Hertzel C Gerstein; Richard H Grimm; Edward W Lipkin; K M Venkat Narayan; Matthew C Riddle; Ajay Sood; David C Goff
Journal:  Diabetes Care       Date:  2014-03-04       Impact factor: 19.112

View more
  7 in total

Review 1.  Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children.

Authors:  Veronica Maria Tagi; Francesca Mainieri; Francesco Chiarelli
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

2.  Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.

Authors:  Elvira O Gosmanova; Margit K Mikkelsen; Miklos Z Molnar; Jun L Lu; Lenar T Yessayan; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  J Am Coll Cardiol       Date:  2016-09-27       Impact factor: 24.094

Review 3.  Diabetic nephropathy: Time to withhold development and progression - A review.

Authors:  Usama A A Sharaf El Din; Mona M Salem; Dina O Abdulazim
Journal:  J Adv Res       Date:  2017-04-21       Impact factor: 10.479

4.  Mendelian randomization analysis of vitamin D in the secondary prevention of hypertensive-diabetic subjects: role of facilitating blood pressure control.

Authors:  Tai-Hing Lam; Karen Siu-Ling Lam; Hung-Fat Tse; Yap-Hang Chan; C Mary Schooling; Jie V Zhao; Shiu-Lun Au Yeung; Jo Jo Hai; G Neil Thomas; Kar-Keung Cheng; Chao-Qiang Jiang; Yuen-Kwun Wong; Ka-Wing Au; Clara S Tang; Chloe Y Y Cheung; Aimin Xu; Pak-Chung Sham
Journal:  Genes Nutr       Date:  2022-01-29       Impact factor: 5.523

5.  Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis.

Authors:  John Peter Mitsios; Elif Ilhan Ekinci; Gregory Peter Mitsios; Leonid Churilov; Vincent Thijs
Journal:  J Am Heart Assoc       Date:  2018-05-17       Impact factor: 5.501

6.  Hypertension Management in Diabetes: 2018 Update.

Authors:  Pasquale Passarella; Tatiana A Kiseleva; Farida V Valeeva; Aidar R Gosmanov
Journal:  Diabetes Spectr       Date:  2018-08

7.  Use of a simplified clinical audit tool to evaluate hypertension and diabetes management in primary care clinics in Jamaica.

Authors:  Jacqueline P Duncan; Marshall K Tulloch-Reid; Heather Reid-Jones; J Peter Figueroa
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-06-09       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.